This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Lieven E C Baert
Introduction
Lieven E C Baert is a notable inventor based in Bruges, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal compositions. His work focuses on improving the bioavailability of existing medications, which can greatly enhance treatment outcomes for patients suffering from fungal infections.
Latest Patents
One of Baert's key patents is for antifungal compositions with improved bioavailability. This invention involves novel pharmaceutical compositions of itraconazole that can be administered to mammals suffering from fungal infections. A single dosage form can be taken once daily, independent of food intake. The compositions consist of particles obtained by melt-extruding a mixture of itraconazole and a suitable water-soluble polymer, followed by milling the melt-extruded mixture. This innovative approach aims to provide more effective treatment options for patients.
Career Highlights
Throughout his career, Baert has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Janssen Pharmaceutica and Tibotec Pharmaceuticals. His experience in these organizations has allowed him to contribute to the development of groundbreaking pharmaceutical solutions.
Collaborations
Baert has collaborated with several professionals in his field, including Dany Thoné and Geert Verreck. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.
Conclusion
Lieven E C Baert's contributions to the pharmaceutical industry, particularly in antifungal treatments, demonstrate his commitment to innovation and improving patient care. His work continues to influence the development of effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
